Review



allogeneic canine smc‐deposited ecm  (Humacyte Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Humacyte Inc allogeneic canine smc‐deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Allogeneic Canine Smc‐Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/allogeneic+canine+smc%E2%80%90deposited+ecm/allogeneic+canine+smc+deposited+ecm/pmc11468936-4-0-46
    Average 90 stars, based on 1 article reviews
    allogeneic canine smc‐deposited ecm - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft"

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    Journal: Advanced Healthcare Materials

    doi: 10.1002/adhm.202200045

    Summary of TEVG studies that involved clinical trials and large animal models
    Figure Legend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Techniques Used: Clinical Proteomics, In Vivo, Infection

    Related Articles

    In Vivo:

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft
    Article Snippet: Allogeneic canine SMC‐deposited ECM , Cell deposition and decellularization , 3–4 , Autologous ECs , In vivo (canine carotid artery bypass graft) , Patency rate was 83% No sign of infection, calcification, aneurysmal dilation, and no intimal hyperplasia at anastomoses up to 1 year , Niklason Lab/Humacyte , Dahl et al., 2011.

    Infection:

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft
    Article Snippet: Allogeneic canine SMC‐deposited ECM , Cell deposition and decellularization , 3–4 , Autologous ECs , In vivo (canine carotid artery bypass graft) , Patency rate was 83% No sign of infection, calcification, aneurysmal dilation, and no intimal hyperplasia at anastomoses up to 1 year , Niklason Lab/Humacyte , Dahl et al., 2011.

    Clinical Proteomics:

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft
    Article Snippet: Allogeneic canine SMC‐deposited ECM , Cell deposition and decellularization , 3–4 , Autologous ECs , In vivo (canine carotid artery bypass graft) , Patency rate was 83% No sign of infection, calcification, aneurysmal dilation, and no intimal hyperplasia at anastomoses up to 1 year , Niklason Lab/Humacyte , Dahl et al., 2011.



    Similar Products

    allogeneic canine smc‐deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc allogeneic canine smc‐deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Allogeneic Canine Smc‐Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/allogeneic+canine+smc%E2%80%90deposited+ecm/allogeneic+canine+smc+deposited+ecm/pmc11468936-4-0-46
    Average 90 stars, based on 1 article reviews
    allogeneic canine smc‐deposited ecm - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Allogeneic canine SMC‐deposited ECM , Cell deposition and decellularization , 3–4 , Autologous ECs , In vivo (canine carotid artery bypass graft) , Patency rate was 83% No sign of infection, calcification, aneurysmal dilation, and no intimal hyperplasia at anastomoses up to 1 year , Niklason Lab/Humacyte , Dahl et al., 2011.

    Techniques: Clinical Proteomics, In Vivo, Infection